Aigen Investment Management LP purchased a new stake in shares of MetLife, Inc. (NYSE:MET – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,232 shares of the financial services provider’s stock, valued at approximately $596,000.
A number of other hedge funds have also recently added to or reduced their stakes in MET. Carmichael Hill & Associates Inc. lifted its holdings in shares of MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares during the last quarter. Wolff Wiese Magana LLC boosted its holdings in shares of MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 277 shares during the period. Fortitude Family Office LLC boosted its holdings in shares of MetLife by 177.3% during the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 266 shares during the period. Bank & Trust Co bought a new position in shares of MetLife during the second quarter worth about $39,000. Finally, Crewe Advisors LLC lifted its position in MetLife by 602.5% in the 2nd quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 482 shares during the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.
MetLife Trading Down 0.2 %
Shares of NYSE:MET opened at $82.02 on Thursday. The stock has a market capitalization of $56.79 billion, a price-to-earnings ratio of 16.54, a PEG ratio of 0.75 and a beta of 1.05. MetLife, Inc. has a 1-year low of $61.16 and a 1-year high of $86.94. The company has a 50 day moving average price of $81.21 and a 200 day moving average price of $75.38. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16.
MetLife Dividend Announcement
Wall Street Analysts Forecast Growth
Several equities research analysts have commented on the stock. Citigroup raised their price target on shares of MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a research note on Tuesday, July 23rd. Barclays lowered their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. TD Cowen started coverage on MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 price target for the company. Jefferies Financial Group raised their price target on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a report on Friday, September 27th. Finally, Bank of America decreased their target price on shares of MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research report on Thursday, August 1st. Fourteen equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, MetLife currently has an average rating of “Buy” and an average target price of $88.46.
Read Our Latest Analysis on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Rocket Lab is the Right Stock for the Right Time
- High Dividend REITs: Are They an Ideal Way to Diversify?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- 3 REITs to Buy and Hold for the Long Term
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.